1. Introduction {#s0005}
===============

The circadian system controls daily rhythms of multiple physiological functions, such as sleep/wake, feeding activity, autonomic nervous system activity, and endocrine hormone release ([@bb0130]). The circadian system exerts its effects *via* a ubiquitously expressed set of genes that form a transcription-translation feedback loop ([@bb0030], [@bb0020]). Namely, PER/CRY act to repress CLOCK/BMAL 1-driven transcription of their own transcripts, thus forming a negative feedback loop. This entire cycle takes approximately 24 h to complete ([@bb0265]). In mammals, the suprachiasmatic nucleus (SCN) in the hypothalamus acts as the master pacemaker and regulator of peripheral clocks ([@bb0170]). Peripheral circadian clocks, which are located in almost every organ demonstrate daily rhythms ([@bb0075]), that are endogenously generated ([@bb0200]). The SCN receives light-dark cycle information directly through the retinal-hypothalamic tract, and is thus synchronized to the external 24-hour environment ([@bb0095]). Downstream peripheral clocks receive information from the SCN through multiple pathways, including autonomic nervous system activity, endocrine hormone release and body temperature ([@bb0025], [@bb0035], [@bb0070], [@bb0110], [@bb0145], [@bb0270]). Additionally, peripheral clocks are thought to be directly entrained by hormones, food, exercise, stress, and drugs, independently of the SCN ([@bb0235], [@bb0185], [@bb0210], [@bb0255]). In particular, food intake induces strong entrainment of peripheral clocks in rodents ([@bb0170], [@bb0220], [@bb0240]), and this phenomenon has also been reported in humans ([@bb0300], [@bb0285]). In our previous study, only one daytime feeding after starvation resulted in large phase shifts in the liver ([@bb0085]); these were caused by daytime feeding-induced increase in *Per2* expression and decrease in *Rev-Erbα* expression ([@bb0245]). However, the same amount of food given in 4 or 6 equal intervals per day did not cause phase shifts in the liver ([@bb0135]). Furthermore, the peripheral clocks of adrenalectomized mice receiving 6 meals a day were remarkably impaired, suggesting that the necessity of the adrenal glands for this entraining effect of food on the liver clock ([@bb0100]). Taken together, our findings demonstrated that maintenance and entrainment of peripheral clock rhythms depend on both daily rhythms of food intake and adrenal gland function.

Food entraining factors such as glucose ([@bb0080], [@bb0090]) and insulin ([@bb0245]) have been previously characterized. These factors induce phase shifts of the liver clock, suggesting that they play an important role in entrainment of peripheral clocks. Insulin induces large phase shifts both *in vitro* ([@bb0245]) and *in vivo* ([@bb0215]). Additionally, peripheral clocks may be entrained by the major nutrients present in a food: α-potato starch is a rapidly digested carbohydrate that increases insulin secretion and causes a large phase shift in the liver clock ([@bb0115]). Fish oil, particularly tuna oil which contains large amounts of the omega-3 fatty acids docosahexaenoic acid (DHA)/eicosapentaenoic acid (EPA), facilitates food-induced entrainment by the activation of insulin secretion through binding to GPR120 which locate on the lower ileum and upper large intestine. As demonstrated in our previous study, fish oil does not cause a phase shift in insulin-depleted mice treated with streptozotocin (STZ), suggesting that this is an insulin-dependent effect ([@bb0060]). On the other hand, Oishi et al. showed that the liver clock of STZ-treated mice lacking insulin can also be entrained by scheduled feeding ([@bb0190]), suggesting that insulin is not necessary for food entrainment of the liver clock. Recently, it was reported that oxyntomodulin, an anorexigenic incretin hormone, entrains the liver clock ([@bb0140]). This finding suggests that additional unknown factors are involved in entrainment of peripheral clocks. Therefore, in this study, to identify additional factors that may be involved in the entrainment of the liver clock, we analyzed whether feeding mice a protein-only diet or specific amino acids that do not increase insulin secretion can cause entrainment of the liver clock. Our findings demonstrated that increasing glucagon and insulin-like growth factor 1 (IGF-1) levels by feeding a protein-only diet entrains the liver circadian clock, both *in vitro* and *in vivo*, in PER2::LUC mice. Moreover, we found that among the 20 amino acids, cysteine has the strongest phase advance *via* increases in IGF-1 in the liver, and this phase advance is inhibited in mice treated with an IGF-1R blocker.

2. Material and Methods {#s0010}
=======================

2.1. Statistical Analysis {#s0015}
-------------------------

For the analyses of the expression of various clock genes and hormone levels, six-week old male ICR mice (Tokyo Laboratory Animals, Tokyo, Japan) were used. For *in vivo* monitoring, 8--15-week old PER2::LUC knock-in heterozygous male mice were used. Mice were bred in house from PER2::LUC homozygous mice (courtesy of Dr. Joseph Takahashi, Northwestern University, Evanston, IL, USA ([@bb0295])) on an ICR background ([@bb0250]). All mice were maintained at a room temperature of 22 ± 1 °C and humidity of 60% ± 5%, under a light-dark cycle (12 h light: lights on between 8:00--20:00; 12 h dark: lights off between 20:00--8:00). The lights-on time was defined as ZT 0 and lights-off time as ZT 12; a light intensity of approximately 100 lx was used at the cage level. Prior to scheduled feeding (SF), all mice were fed a normal rodent diet (EF) (Oriental Yeast Co., Tokyo, Japan), and provided with water *ad libitum*.

All experimental protocols conformed to the laws of the Japanese government and were approved by the Committee for Animal Experimentation of the School of Science and Engineering at Waseda University (permission \#2017-A078).

2.2. Scheduled Feeding of Mice {#s0020}
------------------------------

Mice were subjected to scheduled feeding (AIN-93 M diet, containing 14.0% casein protein, 46.6% β-corn starch (βCS), 15.5% α-corn starch (αCS), 10.0% sucrose, 4.0% soybean oil, 5.0% cellulose powder, 3.5% AIN-93 M mineral mixture, 1.0% AIN-93 M vitamin mixture, 0.25% choline bitartrate, and 0.0008% *tert*-butyl hydroquinone) (Oriental yeast Co., Ltd., Tokyo, Japan) from ZT 13 to ZT 17, for \> 10 days, to entrain liver circadian rhythms. Thereafter, individually housed mice were fed various diets at ZT 5 to determine the phase shift effects of the diets.

2.3. Preparation of Diets With Various Compositions {#s0025}
---------------------------------------------------

During nighttime SF, mice were fed the AIN-93 M diet, as shown in [Fig. 1](#f0005){ref-type="fig"}, [Fig. 2](#f0010){ref-type="fig"}, [Fig. 3](#f0015){ref-type="fig"}, [Fig. 4](#f0020){ref-type="fig"}. For daytime feeding, in [Fig. 2](#f0010){ref-type="fig"}, [Fig. 3](#f0015){ref-type="fig"}a--c, 2 types of diets containing only casein (Oriental Yeast Co., Ltd., Tokyo, Japan) as protein and βCS (Oriental Yeast Co., Ltd., Tokyo, Japan) as carbohydrate were prepared to exclude the effects of other nutritional components. "P" refers to protein (casein) and "C" to carbohydrate (βCS); the number before "P" indicates the percentage of protein, whereas the number before "C" indicates the percentage of carbohydrate. As shown in [Fig. 3](#f0015){ref-type="fig"}, [Fig. 4](#f0020){ref-type="fig"}, in these experiments the 100P/0C diet was used. As indicated in [Fig. 5](#f0025){ref-type="fig"}a, in this experiment a diet with an amino-acid mix to match the amino acid content in the casein protein was prepared. As shown in Supplementary Fig. 1d, 3 types of diets were prepared, differing in the ratio of protein and carbohydrate in the AIN-93 M formula. All diets were composed of casein as protein, βCS as carbohydrate, and the remainder (fat, vitamins, minerals, and cellulose, *etc.*) was not altered. As shown in Supplementary Fig. 4d, diets containing only protein: casein, gluten (Wako, Osaka, Japan), whey (Meiji Dairies Corporation, Tokyo, Japan), or soy (Wako, Osaka, Japan) were used. The amino acid composition of each protein is shown in [Table 2](#t0010){ref-type="table"}. All diets were prepared in tablet form using the tableting machine, HANDTAB-100 (Ichihashi-seiki, Kyoto, Japan).Fig. 1Protein-only diet causes strong phase advance of the liver circadian clock. (a) Experimental schedule. The green square indicates scheduled feeding of a 14% casein protein diet (14P) at ZT 13-17. The orange triangles indicate feeding at ZT 5 for 2 consecutive days. On days 12 and 13, mice were fed 1.0 g and 1.5 g of diet, respectively. The black bar indicates *in vivo* monitoring. (b) Representative images of *in vivo* PER2::LUC bioluminescence in the liver (c) The left graph shows average relative waveforms of *in vivo* PER2::LUC bioluminescence in the Control, the 100P/0C, and the 0P/100C groups. The right graph shows average peak phases of *in vivo* PER2::LUC rhythms in all groups. 100P/0C: 100% casein protein-only diet. 0P/100C: 100% β-cornstarch (βCS)-only diet. Control: n = 8; 100P/0C and 0P/100C: n = 6. (d) Mice were dissected at 6 time points per day (ZT 9, 13, 17, 21, 1, and 5) under the same conditions as those indicated in [Fig. 1](#f0005){ref-type="fig"}a. Relative hepatic mRNA expression levels; n = 5 for all groups at each point. Data are presented as the mean ± SEM. ^\$^*P* \< 0.05, ^\$\$^*P* \< 0.01, ^\$\$\$^*P* \< 0.001 (*vs.* Control), ^¶^*P* \< 0.05 (*vs.* 0P/100C) by one-way ANOVA with Tukey *post-hoc* test, and ^†^*P* \< 0.05, ^††^*P* \< 0.01, ^†††^*P* \< 0.001 (*vs.* Control) by Kruskal-Wallis test with Dunn *post-hoc* test.Fig. 1Fig. 2Protein-only diet increases glucagon and IGF-1 production, resulting in a phase advance both *in vitro* and *in vivo*. The serum or liver samples from the same individual as [Fig. 1](#f0005){ref-type="fig"}d: (a) serum glucagon levels, (b) serum IGF-1 levels, and (c) hepatic IGF-1 levels. Control, 100P/0C, and 0P/100C groups at each point: *n* = 5. (d) Representative PER2::LUC bioluminescence rhythms from liver slices explants of mice under free-feeding conditions. Liver slices were treated with sterile distilled water (Control), 0.5 μM, or 1.0 μM glucagon. Waveforms were smoothened and detrended. (e) Calculated peak phases from d; Control: n = 10; 0.5 μM: n = 9; 1.0 μM: n = 8. (f) Experimental schedule. Under free-feeding conditions, mice were treated with saline (Control group) or 100 μg/kg glucagon at ZT 5 after a 24-h starvation. The blue broken line indicates fasting; the black arrow indicates *in vivo* monitoring. (g) The left graph shows average relative waveforms of hepatic *in vivo* PER2::LUC bioluminescence in the Control and Glucagon groups. The right graph shows average peak phases of *in vivo* PER2::LUC rhythms; Control: n = 4; Glucagon: n = 5. (h) Representative PER2::LUC bioluminescence rhythms from liver slices explants of mice under free-feeding conditions. Liver slices were treated with PBS (Control) or 2000 ng/mL IGF-1. Waveforms were smoothened and detrended. (i) Calculated peak phases from h; Control: n = 6; IGF-1: n = 5. (j) Experimental schedule. Under free-feeding conditions, mice were treated with PBS (Control group) or 1 mg/kg IGF-1 at ZT 5 after a 24-hour starvation. The blue broken line indicates fasting, and the black arrow indicates *in vivo* monitoring. (k) The left graph shows average relative waveforms of hepatic *in vivo* PER2::LUC bioluminescence in the Control and IGF-1 groups. The right graph shows average peak phases of *in vivo* PER2::LUC rhythms; Control: n = 8; IGF-1: n = 10. Data are presented as the mean ± SEM. ^\$\$^*P* \< 0.01 (*vs.* Control), ^¶^*P* \< 0.05, ^¶¶¶^*P* \< 0.001 (*vs.* 0P/100C) by one-way ANOVA with Tukey *post-hoc* test; ^†^*P* \< 0.05, ^††^*P* \< 0.01 (*vs.* Control), ^%^*P* \< 0.05, ^%%^*P* \< 0.01 (*vs.* 0P/100C) by Kruskal-Wallis test with Dunn *post-hoc* test; ^§§^*P* \< 0.01, ^§§§^*P* \< 0.001 (*vs.* Control), ^‡^*P* \< 0.05 (*vs.* 0P/100C) by two-way ANOVA with Tukey *post-hoc* test; \**P* \< 0.05, \*\**P* \< 0.01, \*\*\**P* \< 0.001 (*vs.* Control) by the Student *t*-test; ^\#^*P* \< 0.05, ^\#\#^*P* \< 0.01, ^\#\#\#^*P* \< 0.001 (*vs.* Control) by the Mann-Whitney test.Fig. 2Fig. 3Liver circadian rhythm is also advanced in STZ-treated mice following a protein-only diet. (a) The left graph shows average relative waveforms of hepatic *in vivo* PER2::LUC bioluminescence in STZ-treated mice of the Control and 100P/0C groups. The right graph shows average peak phases of *in vivo* PER2::LUC rhythms. Intact-Control: n = 8; Intact-100P/0C: n = 6; STZ-Control: n = 4; STZ-100P/0C: n = 6. (b) Experimental schedule. The orange triangles indicate feeding times of the 100P/0C diet at ZT 5 for 2 consecutive days. The red arrow indicates dissection time. (c) Relative hepatic mRNA expression levels. (d) Serum glucagon levels. (e) Serum IGF-1 levels. (f) Hepatic IGF-1 levels. Intact-Control: n = 5; Intact-100P/0C: n = 6; STZ-Control: n = 5; STZ-100P/0C: n = 5. Data are presented as the mean ± SEM; \**P* \< 0.05, \*\**P* \< 0.01, \*\*\**P* \< 0.001 (*vs.* Control) by the Student *t*-test; ^\#\#^*P* \< 0.01 (*vs.* Control) by the Mann-Whitney test. ^†^*P* \< 0.05, ^††^*P* \< 0.01 by Kruskal-Wallis test with Dunn *post-hoc* test. ^&&^*P* \< 0.01, ^&&&^*P* \< 0.001 (*vs.* Intact-Control), ^%%^*P* \< 0.01, ^%%%^*P* \< 0.001 (*vs.* STZ-Control), ^\$\$^*P* \< 0.01 (*vs.* Intact-100P/0C) by two-way ANOVA with Tukey *post-hoc* test.Fig. 3Fig. 4Entrainment by a protein-only diet intake is prevented in glucagon- and IGF-1 blockers-treated mice. (a) Experimental schedule. The blue arrows indicate the time of treatment with the glucagon receptor antagonist (GRA) at ZT 4.5. The red arrows indicate time of treatment with the IGF-1R blocker PPP at ZT 6.5. The orange triangles indicate feeding time of the 100P/0C diet at ZT 5. (b, c, d) The left graph shows average relative waveforms of hepatic *in vivo* PER2::LUC bioluminescence in all groups. The right graph shows average peak phases of *in vivo* PER2::LUC rhythms. Control: n = 8; DMSO + 100P/0C + DMSO: n = 5; GRA + 100P/0C + PPP: n = 6; DMSO + 100P/0C: n = 3; GRA + 100P/0C: n = 4; 100P/0C + DMSO: n = 4; 100P/0C + PPP: n = 4. Data are presented as the mean ± SEM. ^\$^*P* \< 0.05, ^\$\$\$^*P* \< 0.001 (*vs.* Control), ^%^*P* \< 0.05 (*vs.* DMSO + 100P/0C) by one-way ANOVA with Tukey *post-hoc* test, and ^†^*P* \< 0.05 (*vs.* Control) by Kruskal-Wallis test with Dunn *post-hoc* test.Fig. 4Fig. 5Single-amino-acid-diet, particularly cysteine, results in phase advance of liver circadian clock. (a) The left graph shows average relative waveforms of hepatic *in vivo* PER2::LUC bioluminescence in the Control and the Amino acids groups. The right graph shows the average peak phases of *in vivo* PER2::LUC rhythms. Control: n = 10; Protein: n = 9; Amino acids: n = 4. (b) Experimental schedule. The green arrows indicate oral administration time of 0.5% CMC (Control) or each of 20 single amino acids at ZT 5 for 3 consecutive days. The orange arrow indicates fasting. (c) Average peak phases of *in vivo* PER2::LUC rhythms in all groups. All groups: n = 4. (d) Phase-response curves following cysteine administration. Increased and decreased phase shifts indicate phase advances and delays, respectively. Control groups at all time points: n = 4; Cysteine groups at ZT 1, 9, 13, and 21: n = 5; Cysteine group at ZT 5: n = 4. Data are presented as the mean ± SEM. ^\$\$\$^*P* \< 0.001 (*vs.* Control), ^%^*P* \< 0.05 by one-way ANOVA with Tukey *post-hoc* test; ^¶^*P* \< 0.05 (*vs.* Control) by the Dunnett test; ^\#^*P* \< 0.05, ^\#\#^*P* \< 0.01 (*vs.* Control) by the Mann-Whitney test.Fig. 5

2.4. Amino Acids {#s0030}
----------------

L-amino acids were used in the experiments. Cysteine and asparagine were obtained from Sigma-Aldrich Co. (St. Louis, USA). Other amino acids were obtained from Wako (Osaka, Japan). All amino acids were dissolved in 0.5% carboxymethyl cellulose (CMC) and administered at a dose of 5 mmol/kg (0.1 mL/10 g body weight), as used in a previous study ([@bb2000]). As shown in Supplementary Fig. 10a and b, mouse embryonic fibroblast (MEF) cells were treated with 0.2, 0.4, or 0.8 mM cysteine dissolved in sterile distilled water.

2.5. Experimental Schedules {#s0035}
---------------------------

### 2.5.1. Feeding of the Protein Diet {#s0040}

In all experiments of the protein diet, mice were subjected to SF with AIN-93 M (14% casein protein diet; 14P) in the dark period, from ZT 13 to ZT 17, for 10 days to entrain liver circadian rhythms. After one day of fasting, mice were fed one of several diets for 2 consecutive days.

In Supplementary Fig. 8, mice were fed AIN-93G (20% casein protein diet; 20P) under free-feeding or ZT 5-9 SF conditions.

### 2.5.2. Administration of Amino Acids {#s0045}

Prior to the experiments, mice were fed EF *ad libitum* in all experiments. Mice were administered 5 mmol/kg of each amino acid at ZT 5 for 3 consecutive days with food *ad libitum*. After the last administration, mice were fasted.

2.6. Recording of Locomotor Activity Rhythms {#s0050}
--------------------------------------------

As shown in Supplementary Fig. 2, general locomotor activity rhythms were recorded under ZT 13-17 SF, 36-hour fasting, and refeeding at ZT 5 for 2 consecutive days with an infrared radiation sensor (F5B; Omron Corporation, Kyoto, Japan) as described previously ([@bb0100]). A representative actogram of double-plotted with 6-min epochs was displayed using ClockLab software (Actimetrics Ltd., Wilmette, USA).

2.7. Drug Treatment {#s0055}
-------------------

To investigate entrainment of the liver circadian clock by glucagon and IGF-1, both *in vivo* and *in vitro*, we used glucagon (Sigma-Aldrich, St. Louis, USA) and human IGF-1 (ProSpec-Tany TechnoGene Ltd., Ness-Ziona, Israel). For *in vitro* and *in vivo* experiments, glucagon was dissolved in sterile distilled water and saline, respectively. Cultured liver slices were stimulated with 0.5 μM or 1.0 μM glucagon. For *in vivo* experiments, glucagon was used at a dose of 100 μg/kg (0.1 mL/10 g body weight) in accordance with that used in a previous study ([@bb0230]). IGF-1 was dissolved in phosphate buffered saline (PBS) for both experiments. Cultured liver slices were stimulated with 2000 ng/mL IGF-1. For *in vivo* experiments, the dose of IGF-1 was 1 mg/kg (0.1 mL/10 g body weight) as used in a previous report ([@bb0105]). Also, as shown in Supplementary Fig. 5, we used insulin from the bovine pancreas (Sigma-Aldrich, St. Louis, USA) as a positive control to confirm entrainment of the liver circadian clock by insulin treatment in the *in vitro* experiments. Cultured liver slices were stimulated with 100 nM or 1.0 μM insulin, as described previously ([@bb0245], [@bb0060]). As shown in [Fig. 3](#f0015){ref-type="fig"}, we used streptozotocin (STZ)-treated mice that were unable to produce insulin: 200 mg/kg STZ (Sigma-Aldrich, St. Louis, USA) was dissolved in saline (0.1 mL/10 g body weight). Mice were treated with STZ at ZT 5 on day 9; then blood glucose levels were measured on day 11. Mice with blood glucose levels higher than 300 mg/dL were used as STZ-treated mice for the experiments. As indicated in [Fig. 4](#f0020){ref-type="fig"}, [Fig. 7](#f0035){ref-type="fig"}, a glucagon receptor antagonist (GRA; ChemScene, NJ, USA) and the IGF-1R blocker picropodophyllin (PPP; Santa Cruz Biotechnology Inc., CA, USA) were used. GRA was dissolved in 5% dimethyl sulfoxide (DMSO), and a dose of 5 mg/kg (0.1 mL/10 g body weight) was used in accordance with a previously reported protocol ([@bb0230]). PPP was dissolved in 5% DMSO, and the dose used was 20 mg/kg (0.2 mL/10 g body weight) in accordance with that in a previous study ([@bb0160]).

2.8. *In Vivo* Monitoring of PER2::LUC Bioluminescence Rhythm {#s0060}
-------------------------------------------------------------

*In vivo* monitoring was performed as previously described ([@bb0250]), using an IVIS kinetics system (Caliper Life Sciences, MA, USA). Briefly, mice were placed inside a black box and anesthetized with isoflurane (Mylan Inc., Tokyo, Japan) and concentrated oxygen (SO-005B, Sanyo Electronic Industries Co. Ltd., Okayama, Japan) using a gas anesthesia system (XGI-8, Caliper Life Sciences, MA, USA). While under anesthesia, mice were injected subcutaneously with D-luciferin potassium salt (Promega, Madison, WI, USA) in the back, near the neck, at a dose of 15 mg/kg (30 mg/ 10 mL PBS; 0.05 mL/ 10 g body weight). Images were taken in the dorsal- and ventral-up position at 8 min (for the kidney) and 10 min (for the liver and submandibular (Sub Gla)) after injection, respectively. Images were captured with a 1-min exposure time. For each time point, the bioluminescence image was merged with the gray-scale image. Images were obtained 6 times per day (ZT 9, 13, 17, 21, 1, and 5) from mice fed each diet or administered each amino acid. Mice were returned to their home cages after each experiment. The total time under isoflurane anesthesia was approximately 20 mins per experiment, from which the mice recovered quickly. Anesthesia and bioluminescence analysis every 4 h did not affect the behavior of mice or luciferase activity in the peripheral organs ([@bb0250]). The bioluminescence emitted from each organ was calculated using Living Image 3.2 software (Caliper Life Sciences, MA, USA). For individual organs, the region of interest was set to the same shape and size throughout all experiments. The average value (photons/s) from the measurements acquired 6 times a day was designated as 100%, and the bioluminescence rhythm for the entire day was expressed as a percentage of the results for each set of 6 measurements for the individual organs. The peak phase of these normalized percentage data was determined using the single cosinor procedure (Acro.exe, version 3.5; designed by Dr. Refinetti).

2.9. Measurement of Hormone Levels {#s0065}
----------------------------------

For the measurement of blood glucose, a small incision was made on the tail vein of each mouse to collect blood. Blood glucose levels were measured using a Glucose PILOT kit (Aventir Biotech, CA, USA) with a range of detection was 20 to 600 mg/dL. For the measurement of serum insulin, glucagon, IGF-1, and corticosterone levels, blood was collected by vein puncture of the eye under anesthesia when mice were sacrificed. Collected blood was left to clot by leaving it at 20 °C for 2 h; then, clots were removed by centrifuging at 3000 rpm at 4 °C for 20 min. The supernatants were stored at − 20 °C until measurement. For measurement of hepatic IGF-1 levels, the livers were removed and immediately stored at − 20 °C. Fifty milligrams of frozen liver from each mouse was homogenized with 800 μL of PBS and were stored at − 20 °C overnight; then, clots were removed by centrifuging at 5000 ×* g* at 4 °C for 5 min. The supernatants were stored at − 20 °C until measurement. Hormone levels of the serum samples were measured with a Mouse Insulin ELISA kit (Mercodia AB, Uppsala, Sweden), Glucagon ELISA kit (Mercodia AB, Uppsala, Sweden), and Corticosterone ELISA kit (Assay Pro, MO, USA). IGF-1 levels in the serum and liver samples were measured using Mouse/Rat IGF-1 ELISA kit (R&D Systems Inc., Minneapolis, USA). All ELISAs were performed in accordance with the manufacturer\'s instructions. Assay detection ranges were insulin: 0 to 6.5 μg/L, glucagon: 0 to 129 pmol/L, IGF-1: 0 to 2000 pg/mL, and corticosterone: 0 to 10,000 ng/mL. The ELISA for IGF-1 measured IGF-1 with the standard length. For measurements of serum insulin and glucagon, undiluted samples were used for ELISA. If the values were higher than the detection limit, samples were diluted by Calibrator 0, thereafter used for the measurements. For measurement of serum corticosterone, samples diluted by a factor of 100 were used for ELISA. For measurement of serum and hepatic IGF-1, samples were diluted by a factor of 500 and 5, respectively.

2.10. Total RNA Isolation and Real Time Reverse-Transcription Polymerase Chain Reaction (RT-PCR) {#s0070}
------------------------------------------------------------------------------------------------

Mice were deeply anesthetized with ether and the livers were collected. The liver samples were subjected to RNA isolation using RNA-*Solv* Reagent (Omega Bio-tek, Inc., GA, USA) in the manufacturer\'s instruction. Total RNA concentration was adjusted to 50 ng/μL using NanoVue (GE Healthcare Japan, Tokyo, Japan). Next, total RNA was subjected to reverse-transcribed and amplified using the One-Step SYBR RT-PCR kit (Takara Bio Inc., Shiga, Japan) with specific primer pairs (listed in [Table 3](#t0015){ref-type="table"}) on a Piko Real PCR system (Thermo Fisher Scientific, MA, USA). The relative expression level of target genes was normalized to that of *Gapdh*. Data were analyzed by the ΔΔ Ct method and melt curve analysis indicated that no amplification of non-specific products had occurred.

2.11. *In Vitro* Recording of PER2::LUC Bioluminescence Rhythm in the Liver Slices and MEF Cells {#s0075}
------------------------------------------------------------------------------------------------

As shown in [Fig. 2](#f0010){ref-type="fig"}d, e, h, i, Supplementary Figs. 5 and 6, an *in vitro* luciferase assay was used to record bioluminescence rhythm in the liver slices. Liver slices from PER2::LUC knock-in mice were prepared and placed in a 35-mm petri dish (AGC Techno Glass Co. Ltd., Tokyo, Japan). Liver slices were cultured in 1.3 mL of Dulbecco\'s modified Eagle medium (DMEM) (Life Technologies, CA, USA) with D-luciferin at 37 °C. Bioluminescence was monitored for 1 min at 10-min intervals using a LumiCycle luminometer (Actimetrics, IL, USA). As shown in [Fig. 2](#f0010){ref-type="fig"} and Supplementary Fig. 5, the dishes of cultured liver slices were removed from the LumiCycle luminometer once at CT 3 after 2.5 h from the bottom and were stimulated with glucagon or IGF-1, and the medium was not changed. The dishes were returned to the luminometer immediately after stimulation was performed. As indicated in Supplementary Fig. 6, liver slices were treated with glucagon or IGF-1 before measurement.

In Supplementary Fig. 10, MEF cells derived from PER2::LUC knock-in mice ([@bb0245]) were used. MEF cells were stimulated with 200 nM dexamethasone for 2 h to synchronize circadian rhythms. Then, 2.0 mL of medium was replaced with DMEM containing 0.1 mM [d]{.smallcaps}-luciferin and 10% fetal bovine serum (FBS) (Bio West, MO, USA). MEF cells were stimulated with vehicle, cysteine or IGF-1 for 30 min at CT 3 after 3 h from bottom. After treatment, the remaining 1.0 mL of medium was replaced; then, the dishes were immediately returned to the luminometer.

2.12. Analysis of Circadian Rhythm in Liver Slices and MEF Cells {#s0080}
----------------------------------------------------------------

Data were detrended by subtracting the 24-hour running average from the raw data using R software (R development Core Team; <http://www.r-project.org/>). Details of the analysis method have been reported previously ([@bb0250]). Peaks were defined as the point at which bioluminescence was higher compared with adjacent points, and confirmed by waveform.

2.13. Statistical Analysis {#s0085}
--------------------------

All data are expressed as the mean ± SEM, and analyzed using GraphPad Prism version 6.03 (GraphPad software, San Diego, USA). We determined whether the data showed a normal or non-normal distribution and equal or biased variation using the D\'Agostino-Pearson/Kolmogorov-Smirnov and *F*-value tests, respectively. Parametric analysis was conducted using a one-way analysis of variance (ANOVA) with Tukey or Student *t*-test for *post-hoc* analysis. The Dunnett test for *post-hoc* analysis was used for comparison with the Control group. Non-parametric analysis was performed using the Dunn or Mann-Whitney test for *post-hoc* analysis. For statistical analysis of RT-PCR and *in vivo* monitoring of time series data, if the data had passed equal variance and normal distribution tests, two-way ANOVA with Tukey or Sidak analysis was performed. If the data did not passed equal variance and normal distribution tests, the Student *t*-test or Mann-Whitney tests was carried out to test for differences between two groups at specific time points. A *P*-value \< 0.05 was considered to indicate a statistically significant difference between two groups.

The Pearson coefficient of correlation was performed in Supplementary Fig. 9.

3. Results {#s0090}
==========

3.1. Proteins Play an Important Role in Food-Induced Entrainment of the Liver Circadian Clock {#s0095}
---------------------------------------------------------------------------------------------

Numerous studies have reported that insulin is an important factor in entrainment of the liver circadian clock ([@bb0080], [@bb0245], [@bb0215]). However, Oishi et al. showed that the liver clock of insulin-depleted mice treated with STZ can also be entrained by SF ([@bb0190]). This report suggested that insulin is not necessary for food entrainment of the liver clock; therefore we analyzed the effects of various dietary components of diet on entrainment of the liver clock to identify factors other than insulin. In this experiment, mice were subjected to SF using AIN-93 M (14% casein protein diet; 14P) in the dark period from ZT 13 to ZT 17 for 10 days to entrain liver circadian rhythms. After a 36-hour starvation, mice were fed the diet for 2 consecutive days (first day, 2.5 g; second day, 3.0 g) at ZT 5. The regular diet (14P) consisted of 14% protein (casein) and 72% carbohydrate (αCS, βCS, and sucrose); total are 86% and the remaining 14% comprised other components. First of all, we confirmed food-induced entrainment of the kidney, liver, and submandibular gland (Sub Gla) by 14P (Supplementary Fig. 1a). After 2 days of daytime feeding, we measured the *in vivo* PER2::LUC bioluminescence rhythms in the kidney, liver, and Sub Gla. The Control group was maintained on night-time SF with 14P from ZT 13 to ZT 17. In the 14P group, the PER2::LUC bioluminescence rhythms in all organs were phase advanced compared with those in the Control group (Supplementary Fig. 1b, c); these results were consistent with those of our previous report ([@bb0250]). Next, we prepared 3 different diets, each containing a different ratio of protein and carbohydrate relative to the AIN-93 M formula. In each diet, casein was used as the protein (P) component, βCS as the carbohydrate (C), and P and C were varied to make up 86% of the diet, with the other components maintained at 14%. For example, in 86P/0C or 0P/86C groups, mice were fed diet containing 86% or 0% casein, 0% or 86% βCS, and 14% other components for 2 consecutive days at ZT 5. After 2 days of daytime feeding of each diet, we measured *in vivo* PER2::LUC bioluminescence rhythms in the liver. In all daytime fed groups, the PER2::LUC peak times in the liver were phase advanced compared with those of the Control group (*P* \< 0.001, one-way ANOVA with Tukey *post-hoc* test, Supplementary Fig. 1d). Low-protein diet groups (6P/80C and 0P/86C) showed larger phase advances than the 86P/0C group (*P* \< 0.01, one-way ANOVA with Tukey *post-hoc* test). Comparison of the 6P/80C and 0P/86C groups, showed that the 6P/80C group had a greater degree of phase advance, confirming the effect of dietary protein on phase advance in circadian rhythm. Therefore, the degree of phase advance depends not on the calorific value of the diets, but on their composition. Interestingly, the 86P/0C diet, which contained a large amount of protein and no carbohydrate, also caused a significant phase advance. Our results indicated that proteins also play an important role in food-induced entrainment of liver circadian clocks.

3.2. Protein-only Diet Causes Strong Phase Advance of the Liver Circadian Clock {#s0100}
-------------------------------------------------------------------------------

We demonstrated that protein is also involved in food-induced entrainment. After a 36-hour starvation, mice were fed the diet for 2 consecutive days (first day, 1.0 g; second day, 1.5 g) at ZT 5 ([Fig. 1](#f0005){ref-type="fig"}a). After 2 days of daytime feeding, we measured *in vivo* PER2::LUC bioluminescence rhythms in the liver. First of all, locomotor activity rhythms were not different among mice refed the different types of diets at ZT 5 (Supplementary Fig. 2), and the amount of locomotor activity did not decrease by a 36-hour starvation (data not shown). In addition, the body-weight loss rate was 11.3 ± 0.51% by a 36-hour starvation (n = 40); and hence the mice were not weakening. As a result of *in vivo* PER2::LUC bioluminescence rhythms, both diets elicited the same degree of phase shift (*P* \< 0.001, one-way ANOVA with Tukey *post-hoc* test, [Fig. 1](#f0005){ref-type="fig"}b, c). Next, we collected livers 6 times throughout a day (every 4 h) in the Control, 100P/0C, and 0P/100C groups to measure relative mRNA expression levels of other clock genes ([Fig. 1](#f0005){ref-type="fig"}d). The mean, amplitude, acrophase, goodness of fit, and *P*-values of all clock genes were analyzed by cosinor fitting ([Table 1](#t0005){ref-type="table"}). As a result, the 100P/0C group produced an 8.0 h (*Per1*), 6.4 h (*Per2*), 4.8 h (*Rev-Erbα*), 4.8 h (*Bmal1*), and 5.6 h (*Dbp*) phase advance compared with the Control group. On the other hand, the 0P/100C group produced an 8.4 h (*Per1*), 6.4 h (*Per2*), 5.6 h (*Rev-Erbα*), 4.0 h (*Bmal1*), and 6.8 h (*Dbp*) phase advance compared with the Control group. These results indicate that the protein-only diet also elicited a strong phase advance of the liver circadian clock. We previously reported that a balanced diet (AIN-93M) entrains peripheral clocks by increasing blood glucose and serum insulin levels ([@bb0080]). Furthermore, it has been reported that glucocorticoid treatment affects the entrainment of peripheral clocks, particularly those of the kidney and lung ([@bb0015], [@bb0225]). Therefore, we measured blood glucose, serum insulin, and serum corticosterone levels at 6 time points in the same samples as in [Fig. 2](#f0010){ref-type="fig"}d (Supplementary Fig. 3). In the 100P/0C group, blood glucose and serum insulin levels did not increase or decrease, whereas in the 0P/100C group, serum insulin levels significantly increased throughout the day compared with the Control and 100P/0C groups. On the other hand, serum corticosterone levels were significantly increased at ZT 9, 17, 1, and 5 by a 100P/0C diet feeding (*P* \< 0.05, Tukey or Dunn test). Previously, Oishi et al. reported that a high-protein diet intake under free-feeding conditions increases serum corticosterone levels ([@bb0195]); the present results were consistent with these findings. As insulin is a fast-changing hormone after feeding, we analyzed acute serum insulin levels 90 min after the intake of each diet (Supplementary Fig. 4a). The serum insulin level was not affected by the 100P/0C diet, but significantly increased following intake of the 0P/100C diet (*P* \< 0.001, one-way ANOVA with Tukey *post-hoc* test, Supplementary Fig. 4b). In the liver, *Per2* expression levels of both groups were increased significantly in response intake of the diet compared with that in the Control group, whereas *Per1* expression levels were increased by intake of the 100P/0C diet but not by 0P/100C (Supplementary Fig. 4c). Thus, the P/C ratio of the diet affected *Per1* and *Per2* gene expression. Furthermore, we tested various types of protein (casein- , gluten- , whey- , and soy-derived proteins) to determine whether they exert different entraining effects. We added the non-caloric sweetener sucralose (0.1 mg/g diet) to entice the mice to eat the provided food because mice hesitated to eat these protein-only diets. [Table 2](#t0010){ref-type="table"} indicates the amino-acid composition of each protein. To analyze the effect of the added sucralose, we also prepared an casein protein-only (non-sucralose) group. *Per2* expression levels in the livers of all groups were significantly increased compared with those in the Control group (*P* \< 0.05, one-way ANOVA with Tukey *post-hoc* test) but there were no differences among the protein sources. The Casein + Sucralose group tended to show lower *Per2* expression levels than the Casein group (Supplementary Fig. 4d).Table 1Mean, amplitude, acrophase, goodness of fit, and *P*-values evaluated by cosinor fitting.Table 1MeanAmplitudeAcrophaseGoodness of fit*P-*value*Clock genes*[Fig. 1](#f0005){ref-type="fig"}*Per1*Control8.5974.72412.20.179\> 0.05100P/0C13.8713.1944.20.086\> 0.050P/100C9.6647.9273.80.093\> 0.05*Per2*Control6.7643.69611.40.04\< 0.01\*\*100P/0C6.3054.3815.00.067\< 0.05\*0P/100C8.3695.9245.00.061\< 0.05\**Rev-Erbα*Control16.83219.5745.00.05\< 0.02\*100P/0C13.80415.5560.20.05\< 0.02\*0P/100C17.84618.30223.40.05\< 0.02\**Bmal1*Control13.9813.40421.80.003\< 0.001\*\*\*100P/0C14.79211.05517.00.035\< 0.01\*\*0P/100C18.71614.81117.80.058\< 0.05\**Dbp*Control50.23965.6229.00.032\< 0.01\*\*100P/0C38.79350.6663.40.042\< 0.01\*\*0P/100C25.19340.3852.20.12\> 0.05[Fig. 6](#f0030){ref-type="fig"}*Per1*Control7.5313.02610.60.237\> 0.05Cysteine6.7554.9234.20.192\> 0.05*Per2*Control4.4272.98710.20.057\< 0.05\*Cysteine4.663.3294.60.046\< 0.02\**Rev-Erbα*Control8.33211.484.20.074\< 0.05\*Cysteine10.90212.1520.60.018\< 0.001\*\*\**Bmal1*Control9.7147.57720.20.01\< 0.001\*\*\*Cysteine7.3627.69417.80.023\< 0.005\*\**Dbp*Control6.3935.6359.00.071\< 0.05\*Cysteine8.1297.4313.40.027\< 0.005\*\*  *Hormones*[Fig. 2](#f0010){ref-type="fig"}Serum glucagonControl5.6510.61613.40.313\> 0.05100P/0C9.664.45111.00.011\< 0.001\*\*\*0P/100C4.7480.8229.00.3\> 0.05Serum IGF-1Control556.97176.18411.80.157\> 0.05100P/0C564.14131.52113.00.141\> 0.050P/100C416.62184.22811.80.084\> 0.05Hepatic IGF-1Control66.09523.07319.40.232\> 0.05100P/0C70.01812.20412.60.026\< 0.005\*\*0P/100C55.6513.51911.80.359\> 0.05[Fig. 6](#f0030){ref-type="fig"}Hepatic IGF-1Control97.661.94212.60.446\> 0.05Cysteine100.6642.50819.00.206\> 0.05Serum IGF-1Control643.54188.22210.60.192\> 0.05Cysteine737.57975.42212.60.066\< 0.05\*Supplementary Fig. 3Blood glucoseControl154.43360.211.00.103\> 0.05100P/0C157.36723.614.20.164\> 0.050P/100C160.00066.09.40.168\> 0.05Serum insulinControl0.5690.65510.20.148\> 0.05100P/0C0.5250.47911.40.027\< 0.005\*\*0P/100C1.3880.759.80.164\> 0.05Serum corticosteroneControl293.947140.93313.80.516\> 0.05100P/0C761.344702.873.80.255\> 0.050P/100C273.822131.712.20.026\< 0.005\*\*[^1]Table 2Amino-acid composition proteins used in this study.Table 2g/100 g protein dietCaseinGlutenWheySoyIsoleucine4.853.34.443.94Leucine8.796.19.946.79Valine6.173.94.414.09Methionine2.711.351.81.1Cysteine0.320.752.51.08Phenylalanine4.814.43.024.53Tyrosine5.212.653.023.24Threonine4.082.054.343.33Tryptophan1.14--1.91.18Lysine7.552.47.855.37Histidine2.881.81.932.28Arginine3.492.652.286.57Glycine1.713.051.653.57Serine5.253.253.784.41Alanine2.82.453.923.6Proline10.110.553.854.57Aspartic acid6.692.89.3810.1Glutamic acid21.229.513.616.9Table 3Primer sequences used in this study.Table 3*Gapdh*5′-tggtgaaggtcggtgtgaac-3′5′-aatgaaggggtcgttgatgg-3′*Per1*5′-caagtggcaatgagtccaacg-3′5′-cgaagtttgagctcccgaagtg-3′*Per2*5′-tgtgtgcttacacgggtgtccta-3′5′-acgtttggtttgcgcatgaa-3′*Rev-Erbα*5′-cttccgtgacctttctcagc-3′5′-cagctcctcctcggtaagtg-3′*Bmal1*5′-ccacctcagagccattgataca-3′5′-gagcaggtttagttccactttgtct-3′*Dbp*5′-ccgtggaggtgctaatgacct-3′5′-cctctgagaagcggtgcct-3′

We previously reported that decreased caloric consumption caused a phase advance of peripheral clocks *in vivo* ([@bb0135]). To determine whether a phase advance in response to the 100P/0C diet depends on the time of feeding, we investigated mice that were fed the same type and amount of food as shown in [Fig. 2](#f0010){ref-type="fig"} at ZT 13, the time of initiation of SF (Supplementary Fig. 4e). The results showed that feeding of the same amount (1.0 g + 1.5 g) of diet with the same composition of protein and carbohydrate diet at ZT 13 did not change the phase. This suggests that our findings could not be attributed to the decreased caloric intake of the day-fed 100P/0C and 0P/100C groups (Supplementary Fig. 4f).

Hence, we concluded that the protein-only diet also causes strong entrainment, so the liver clock depends on feeding time but is independent of insulin secretion.

3.3. Increase in Glucagon and IGF-1 Levels Following Protein-Only Diet Intake Causes Phase Advance {#s0105}
--------------------------------------------------------------------------------------------------

We demonstrated that the protein-only diet caused a phase advance in the liver. Next, we attempted to identify factors that contribute to this insulin-independent entrainment. Several reports showed that intake of a high-protein meal increased serum glucagon levels in humans ([@bb0120], [@bb0005]). Furthermore, it has been shown that a diet in which over 20% of total calorie intake is accounted for by protein increases serum IGF-1 levels in adults aged 50--65 years ([@bb0155]). Therefore, we next measured glucagon levels in the serum and IGF-1 levels in the serum and liver at 6 time points over a 24-hour duration (see [Fig. 1](#f0005){ref-type="fig"} for dissection time). We found that the levels of serum glucagon and hepatic IGF-1 levels were increased after consumption and remained high for 8 or 4 h, respectively (glucagon; *P* \< 0.05, Dunn *post-hoc* test, IGF-1; *P* \< 0.05, two-way ANOVA with Tukey *post-hoc* test). In addition, although serum glucagon and hepatic IGF-1 levels of the Control and 0P/100C groups were nonrhythmic, those of the 100P/0C group became rhythmic ([Fig. 2](#f0010){ref-type="fig"}a, c). Serum IGF-1 levels were not altered by 100P/0C diet intake compared with the Control group, but when compared with the 0P/100C group, its level at ZT 17 significantly increased (*P* \< 0.05, two-way ANOVA with Tukey *post-hoc* test, [Fig. 2](#f0010){ref-type="fig"}b). These results suggest that glucagon and IGF-1 production in mice fed the protein-only diet might contribute to entrainment of the liver clock.

We next investigated the effect of glucagon and IGF-1 on liver circadian rhythm *via in vitro* and *in vivo* assays. Before the experiments, we confirmed entrainment by insulin stimulation as a positive control on liver circadian rhythm in an *in vitro* assay (Supplementary Fig. 5). We stimulated cultured PER2::LUC liver slices with 100 nM or 1.0 μM insulin at CT 3. The peak of the subsequent peak (peak 2) was significantly advanced (*P* \< 0.05, one-way ANOVA with Tukey *post-hoc* test), and peak 3 had a tendency to advance (Supplementary Fig. 5b). These results were consistent with previous reports ([@bb0290], [@bb0215]). With these results, we concluded that the method for the *in vitro* assay was reliable. Next, we stimulated cultured PER2::LUC liver slices with 0.5 μM or 1.0 μM glucagon at CT 3. In the glucagon-treated groups, the amplitude of PER2::LUC bioluminescence was increased ([Fig. 2](#f0010){ref-type="fig"}d), and the phase of the subsequent peak (peak 2) was significantly advanced (*P* \< 0.05, Dunn *post-hoc* test, [Fig. 2](#f0010){ref-type="fig"}e). Furthermore, we analyzed the effect of glucagon on the circadian period of the liver without changing the culture medium in the dishes. Glucagon treatment did not alter the liver circadian period (Supplementary Fig. 6a). To confirm these findings *in vivo*, mice fasted for 24 h were injected with 100 μg/kg glucagon at ZT 5; and the PER2::LUC bioluminescence rhythms in the liver were measured ([Fig. 2](#f0010){ref-type="fig"}f). In the glucagon-treated group, the liver clock showed a significant phase advance (*P* \< 0.05, Student *t*-test, [Fig. 2](#f0010){ref-type="fig"}g). Similarly, we stimulated cultured PER2::LUC liver slices with 2000 ng/mL IGF-1. In the IGF-1-treated group, the phase of the subsequent peak (peak 2) was slightly advanced and peak 3 was significantly advanced (*P* \< 0.05, Student *t*-test, [Fig. 2](#f0010){ref-type="fig"}h, i). The IGF-1-treatment did not alter the circadian period of the liver (Supplementary Fig. 6b). To confirm these findings *in vivo*, mice fasted for 24 h were injected with 1 mg/kg IGF-1 at ZT 5; and the PER2::LUC bioluminescence rhythms in the liver were measured ([Fig. 2](#f0010){ref-type="fig"}j). In the IGF-1-treated group, the liver clock showed a significant phase advance (*P* \< 0.05, Mann-Whitney test, [Fig. 2](#f0010){ref-type="fig"}k). These *in vivo* results indicated that both glucagon and IGF-1 entrain liver circadian clocks; furthermore, the *in vitro* results indicate that glucagon may have a transient effect and IGF-1 may have a sustained effect. Taken together, the present findings indicate that a protein-only diet entrains liver circadian clocks by increasing glucagon secretion and/or IGF-1 production in the liver.

3.4. Liver Circadian Rhythm is Also Advanced in STZ-treated Mice Following a Protein-only Diet {#s0110}
----------------------------------------------------------------------------------------------

We demonstrated that the intake of a protein-only resulted in a phase advance independently of insulin secretion. Accordingly, we used STZ-treated mice that lack insulin secretion to analyze the effect of a protein-only diet on the entrainment of liver circadian clocks. Mice were treated with 200 mg/kg STZ on day 9, and their blood glucose levels were measured on day 11. We used mice whose blood glucose levels were higher than 300 mg/dL as STZ-treated mice in these experiments. Under the same experimental schedule as shown in [Fig. 1](#f0005){ref-type="fig"}a, we measured the *in vivo* PER2::LUC bioluminescence rhythms in the liver. The data of Intact mice groups were the same as those shown in [Fig. 1](#f0005){ref-type="fig"}c. The blood glucose levels of STZ-treated mice before and after STZ treatment are shown in Supplementary Fig. 7a. The average relative waveform and amplitude of *in vivo* PER2::LUC bioluminescence did not differ between Intact and STZ-treated Control groups (data not shown); however, the average raw waveform of *in vivo* PER2::LUC bioluminescence differed between the 2 groups. In the STZ-treated Control group, the raw bioluminescence at ZT 17 and amplitude decreased significantly compared with that of the Intact Control group (*P* \< 0.05, Student *t*-test, Supplementary Fig. 7b). This result was consistent with that of [@bb0190]. Furthermore, we found that the protein-only diet also caused a phase advance of liver circadian rhythm in STZ-treated mice (*P* \< 0.001, two-way ANOVA with Tukey *post-hoc* test, [Fig. 3](#f0015){ref-type="fig"}a). Next, we sacrificed Intact and STZ-treated mice fed a protein-only diet to analyze hormone levels and hepatic mRNA expression levels of clock genes ([Fig. 3](#f0015){ref-type="fig"}b). The blood glucose levels in STZ-treated mice before and after STZ treatment are shown in Supplementary Fig. 7c. Serum insulin levels of STZ-treated mice could not be calculated accurately, because the values for most samples were lower than those of the blank well, indicating that STZ-treated mice underwent pancreatic β-cell loss. The time of dissection (ZT 9) was the timepoint at which serum glucagon and hepatic IGF-1 levels increased in the 100P/0C group ([Fig. 2](#f0010){ref-type="fig"}a, c). We measured relative hepatic mRNA expression levels of clock genes, serum glucagon, and serum/hepatic IGF-1 levels. In Intact mice, clock gene expression patterns ([Fig. 3](#f0015){ref-type="fig"}c) corresponded with that shown in [Fig. 1](#f0005){ref-type="fig"}d. Similar changes were also observed in STZ-treated mice; however, *Rev-Erbα* and *Dbp* expression levels were decreased compared with those in the Intact mice groups. In Intact mice, serum glucagon and serum/hepatic IGF-1 levels, as shown in [Fig. 3](#f0015){ref-type="fig"}d, e, and f, corresponded with that in [Fig. 2](#f0010){ref-type="fig"}a, b, and c. In STZ-treated mice fed a protein-only diet, hepatic IGF-1 levels significantly increased (*P* \< 0.01, two-way ANOVA with Tukey *post-hoc* test); however, the serum glucagon levels did not increase. Taken together, STZ-treated mice also underwent a phase advance of the liver circadian clock following intake of a protein-only diet; in particular, IGF-1 production in the liver was found to be a key factor in the entrainment of the liver circadian rhythm. We therefore next investigated whether glucagon and/or IGF-1 production is involved in scheduled feeding entrainment by a normal diet. We used AIN-93G (20P), which contains slightly more protein that a normal diet (14P), to reflect effects of protein. Mice were divided into 2 groups: (1) free-feeding (FF) and (2) daytime SF (ZT 5-9 SF). After 1 week, mice were sacrificed at ZT 5 (prior to SF) and ZT 9 to analyze the hepatic mRNA expression levels of clock genes and hormone levels (Supplementary Fig. 8a). As shown in Supplementary Fig. 8b, expression of hepatic clock genes at ZT 5 was affected by daytime SF, and moreover, the expression levels of all of the clock genes measured were significantly changed by daytime SF (*P* \< 0.05, Student *t*-test or Mann-Whitney test). These results were consistent with previous reports ([@bb0125], [@bb0245]). In addition, blood glucose and serum insulin levels significantly increased in response to daytime feeding (*P* \< 0.05, Dunn *post-hoc* test), whereas serum corticosterone levels did not change (Supplementary Fig. 8c, d, e). Furthermore, above all, serum glucagon level also increased significant by daytime scheduled feeding (*P* \< 0.001, two-way ANOVA with Tukey *post-hoc* test). However, serum/hepatic IGF-1 levels did not change (Supplementary Fig. 8f, g, h). Taken together, these results indicate that under normal conditions, insulin and glucagon act as entrainment factors of scheduled feeding. On the other hand, IGF-1 may be involved when the compensatory entrainment pathway is necessary in specific situations, such as diabetes.

3.5. Entrainment by a Protein-only Diet is Prevented by Inhibition of Glucagon and IGF-1 Signaling {#s0115}
--------------------------------------------------------------------------------------------------

To elucidate the involvement of glucagon and IGF-1 pathways in changes in the liver circadian clock induced by a protein-only diet, we used blocker double-treated mice. In these mice, glucagon receptors were blocked with glucagon receptor antagonist (GRA) and the IGF-1 receptor was blocked with pocropodophyllin (PPP). In this experiment, mice were treated with 5 mg/kg GRA at ZT 4.5, fed a protein-only diet at ZT 5, and treated with 20 mg/kg PPP at ZT 6.5 for 2 consecutive days ([Fig. 4](#f0020){ref-type="fig"}a). We measured the *in vivo* PER2::LUC bioluminescence rhythms in the liver. The data of the Control group were the same as those shown in [Fig. 1](#f0005){ref-type="fig"}c. As a result, the peak phase advance was significantly prevented in GRA- and PPP-double-treated mice compared with that in vehicle (DMSO)-treated mice (*P* \< 0.05, one-way ANOVA with Tukey *post-hoc* test, [Fig. 4](#f0020){ref-type="fig"}b). We additionally analyzed the preventive effect of single-drug treatment ([Fig. 4](#f0020){ref-type="fig"}c, d). In the GRA-treated group, phase advance following the intake of the protein-only diet was not prevented. On the other hand, PPP treatment significantly prevented phase advance following intake of the protein-only diet compared with that observed following DMSO treatment (*P* \< 0.05, one-way ANOVA with Tukey *post-hoc* test). However, simultaneous treatment with both drugs exerted a stronger preventive effect than the single treatment. Thus, we demonstrated the necessity of both glucagon and IGF-1 production for changes in liver circadian rhythm following the intake of a protein-only diet.

3.6. Single-amino-acid-diet, Particularly Cysteine, Results in Phase Advance of the Liver Circadian Clock {#s0120}
---------------------------------------------------------------------------------------------------------

We demonstrated that a protein-only diet causes a strong phase advance in the liver circadian clock *via* glucagon and IGF-1. We hence hypothesized that particular amino acids found in casein may exert entrainment effects on the liver circadian clock; accordingly, we investigated whether an amino acid-only diet affects the liver circadian clock through *in vivo* PER2::LUC bioluminescence rhythms. Similar to a protein-only diet, the peak phase advance was caused by an amino acid-only diet (*P* \< 0.001, one-way ANOVA with Tukey *post-hoc* test). However, the entrainment effect elicited by the amino acid-only diet was weaker than that elicited by the protein-only diet ([Fig. 5](#f0025){ref-type="fig"}a). This difference may be attributable to the digestion of proteins into amino acids; in other words, proteins exert entrainment effects *via* their activity as both proteins and amino acids. Next, to identify which amino acid had the strongest entrainment effect on the liver circadian clock, we investigated the effect of the administration of each amino acid. Mice were administered single amino acids (5 mmol/kg) at ZT 5 for 3 consecutive days; then, the *in vivo* PER2::LUC bioluminescence rhythms in the liver were measured ([Fig. 5](#f0025){ref-type="fig"}b). Cysteine, leucine, and histidine administration caused phase advance in the liver circadian clock; that a phase advance by cysteine was statistically significant (*P* \< 0.05, Dunnett test, [Fig. 5](#f0025){ref-type="fig"}c). We calculated the correlation between the content of each amino acid content in the casein protein and the phase shift in the liver compared with that in the Control group (Supplementary Fig. 9). Neither group demonstrated a correlation (Pearson coefficient of correlation *R* = − 0.3839, *P* = 0.1157); therefore, the phase shift following the administration of each amino acid was not associated with amino acid content in the normal diet. We focused on cysteine, as this amino acid exerted the strongest entrainment among all amino acids analyzed. Phase response curves (PRC) were generated by analyzing phase shift values following cysteine administration ([Fig. 5](#f0025){ref-type="fig"}d). In the dark period, cysteine had no effect on phase shift. On the other hand, in the light period, cysteine administration caused a significant phase advance (*P* \< 0.05, Mann-Whitney test).

Taken together, amino acids cause phase shift in the liver circadian clock; in particular, cysteine administration in the light period had the strongest entrainment among all the amino acids analyzed individually.

3.7. Cysteine Administration Induces Phase Advance of the Liver Clock by Increasing IGF-1 Levels {#s0125}
------------------------------------------------------------------------------------------------

We demonstrated that cysteine administration caused a phase advance in the liver circadian clock. Previous reports have shown that cysteine intake upregulates IGF-1 production in the liver ([@bb0175]); thus to investigate the association between cysteine administration and IGF-1, we sacrificed mice administered cysteine at ZT 5 for 3 consecutive days at 6 time points, every 4 h throughout the day ([Fig. 6](#f0030){ref-type="fig"}a). The mean, amplitude, acrophase, goodness of fit, and *P*-values of all clock genes were analyzed by cosinor fitting ([Table 1](#t0005){ref-type="table"}). The Cysteine group showed phase advances of 6.4 h (*Per1*), 5.6 h (*Per2*), 3.6 h (*Rev-Erbα*), 2.4 h (*Bmal1*), and 5.6 h (*Dbp*) compared with the Control group ([Fig. 6](#f0030){ref-type="fig"}b). Moreover, we analyzed serum and hepatic IGF-1 levels, and found that serum and hepatic IGF-1 levels were higher in the Cysteine group than in the Control groups at all time points; hence, the average IGF-1 level at all 6 time points in both the serum and liver significantly increased in the Cysteine group compared with in the Control group (*P* \< 0.05, Student *t*-test, [Fig. 6](#f0030){ref-type="fig"}c, d). Furthermore, we investigated entrainment by cysteine or IGF-1 treatment in MEF cells. We stimulated MEF cells with 0.2, 0.4, or 0.8 mM cysteine. These concentrations were chosen because DMEM contains approximately 0.4 mM cysteine. For IGF-1-treatment, MEF cells were stimulated with 1000, 2000, or 4000 ng/mL IGF-1. Cysteine treatment did not alter circadian rhythm in MEF cells (Supplementary Fig. 10a, b); however, the IGF-1-treatment altered the circadian rhythm of these cells, and the phase of the subsequent peak (peak 2) was significantly advanced (*P* \< 0.05, Dunnett test, Supplementary Fig. 10c, d). Taken together, cysteine itself does not alter the circadian rhythm; however, the circadian rhythm is altered in response to IGF-1 production *in vivo* following cysteine administration.Fig. 6Cysteine administration induces a phase advance of the liver circadian clocks *via* increased IGF-1 production in the liver. (a) Experimental schedule. The green arrows indicate oral administration time of 0.5% CMC (Control) or Cysteine at ZT 5 for 3 consecutive days. The orange arrow indicates fasting. (b) Relative hepatic mRNA expression levels; the left graph shows IGF-1 levels at 6 time points per day. The right graph shows average IGF-1 levels at all time points (c) in the liver, and (d) in the serum. The Control and Cysteine groups at each point: n = 5. Data are presented as the mean ± SEM. \**P* \< 0.05, \*\**P* \< 0.01, \*\*\**P* \< 0.001 by the Student *t*-test; ^\#^*P* \< 0.05, ^\#\#^*P* \< 0.01 (*vs.* Control) by the Mann-Whitney test. ^&^*P* \< 0.05 (*vs.* Control) by two-way ANOVA with Sidak *post-hoc* test.Fig. 6

3.8. Entrainment by Cysteine Administration Is Prevented in PPP-treated Mice {#s0130}
----------------------------------------------------------------------------

We demonstrated that cysteine administration causes a phase advance *via* increased hepatic IGF-1 levels. We therefore next investigated whether a phase advance caused by cysteine administration can be prevented by IGF-1R blocker treatment. In this experiment, mice were administered 5 mmol/kg cysteine at ZT 5, thereafter mice were treated with 20 mg/kg PPP at ZT 6.5 for 3 consecutive days ([Fig. 7](#f0035){ref-type="fig"}a). Cysteine and PPP were dissolved in 0.5% CMC and 5% DMSO, respectively. The Control group was administered 0.5% CMC at ZT 5, and treated with 5% DMSO at ZT 6.5. We measured the *in vivo* PER2::LUC bioluminescence rhythms in the liver. As a result, the peak phase was significantly advanced in the DMSO-treated and Cysteine-administered group compared with that in the Control group (*P* \< 0.05, one-way ANOVA with Tukey *post-hoc* test, [Fig. 7](#f0035){ref-type="fig"}b). In summary, we showed that IGF-1 production is necessary for cysteine administration-induced changes in the liver circadian clock (Supplementary Fig. 11).Fig. 7Entrainment by cysteine administration is prevented in PPP-treated mice. (a) Experimental schedule. The green arrows indicate oral administration time of 0.5% CMC (Control) or Cysteine at ZT 5 for 3 consecutive days. The red arrows indicate time of treatment with the IGF-1R blocker PPP at ZT 6.5 for 3 consecutive days. The orange arrow indicates fasting. (b) The left graph shows average relative waveforms of hepatic *in vivo* PER2::LUC bioluminescence in all groups. The right graph shows average peak phases of *in vivo* PER2::LUC rhythms. Control: n = 5; Cysteine + DMSO: n = 5; Cysteine + PPP: n = 4. Data are presented as the mean ± SEM. ^%^*P* \< 0.05, ^%%^*P* \< 0.01 (*vs.* Control), ^&^*P* \< 0.05 (*vs.* Cysteine + DMSO) by two-way ANOVA with Tukey *post-hoc* test, and ^\$^*P* \< 0.05 (*vs.* Control) by one-way ANOVA with Tukey *post-hoc* test.Fig. 7

4. Discussion {#s0135}
=============

Numerous studies have reported that insulin is an important factor in the entrainment of the liver circadian clock ([@bb0080], [@bb0245], [@bb0215]). However, STZ-treated mice lacking insulin may be entrained by scheduled feeding ([@bb0190]), suggesting that insulin is sufficient, but not necessary, for food-induced entrainment. In this study, we analyzed whether intake of a protein-only diet or administration of particular amino acids, which do not increase insulin secretion, cause entrainment of the liver clock.

Our findings indicate that a protein-only diet causes a significant phase advance of the clock genes *Per1*, *Per2*, *Rev-Erbα*, *Bmal1*, and *Dbp* in the liver, independently of insulin secretion ([Fig. 1](#f0005){ref-type="fig"} and Supplementary Fig. 4). Accordingly, we investigated entrainment in response to protein-only intake to identify causal factors other than insulin. We observed that a protein-only diet caused a phase advance by increasing glucagon secretion and IGF-1 production ([Fig. 2](#f0010){ref-type="fig"}a, c). Recently, it was reported that serum glucagon and serum/hepatic IGF-1 levels show circadian rhythmicity in wild-type (WT) mice fed *ad libitum*. The level of circulating glucagon was the highest at ZT 12 and the lowest at ZT 0; however, the circadian rhythm of glucagon changed to an anti-phase in mice subjected to scheduled feeding at ZT 0 ([@bb0180]). On the other hand, the level of circulating IGF-1 was higher in the serum during early daytime and in the later part of the night-time in the liver, but lower at night-time in the serum and in the daytime in the liver ([@bb0040], [@bb0205]). In the present study, serum glucagon and serum/hepatic IGF-1 did not show significant rhythmicity, although the levels of circulating glucagon showed a peak at around ZT 13.4 in the Control group ([Fig. 2](#f0010){ref-type="fig"}a, [Table 1](#t0005){ref-type="table"}). Therefore, the serum glucagon and serum/hepatic IGF-1 rhythms were different under ZT 13-17 SF condition (the Control group in this study) and free-feeding conditions. However, this did not appear to have a large effect on circadian rhythms in the liver.

Interestingly, circadian clock genes control IGF-1 levels. It was previously reported that *Cry1, 2*-double deficient mice reduced IGF-1 production ([@bb0040]), and *Bmal1* deficient mice altered the rhythm of circulating IGF-1 in the serum ([@bb0205]). It was also reported that clock genes and clock-controlled genes regulate metabolic rhythms ([@bb0165]). Taken together, the increase in IGF-1 levels by a protein-rich diet may be ineffective for phase shifts of peripheral clocks in clock gene-mutant and deficient mice. Additionally, it is known that the levels of circulating IGF-1 is decreased and circadian rhythm is disrupted with age, leading to defects in daily hormonal rhythm and multiple physiological functions ([@bb0275]). In this study, we used young WT mice; therefore it is not clear whether a similar phenomenon would also be observed in mice with clock gene mutations, deficiencies, or aged mice. Therefore, future studies are necessary under conditions of circadian rhythm impairment.

Our results showed that levels of serum glucagon and hepatic IGF-1 remained high for 8 or 4 h after a protein-only diet intake, and became rhythmic ([Fig. 2](#f0010){ref-type="fig"}a, c). We confirmed the abilities of glucagon and IGF-1 to alter liver circadian rhythm *in vitro* and *in vivo* using PER2::LUC mice ([Fig. 1](#f0005){ref-type="fig"}d--k). Recently, it was reported that glucagon regulates *Bmal1* expression in the liver ([@bb0230]). Sun et al. demonstrated an increase in *Bmal1* expression in mice 4 h after treatment with glucagon. Our results demonstrated an increase in *Bmal1* expression 4 h after the feeding of a protein-only diet in mice; these findings were very similar to those of Sun et al. Additionally, Sun et al. showed that glucagon signaling activates *Bmal1* expression through the induction of phosphorylated-CREB (pCREB); accordingly, it is possible that in the present study, the protein-only diet altered liver circadian rhythm through the induction of pCREB. On the other hand, the entrainment mechanism of liver circadian rhythm by IGF-1 treatment was not clear, but the events occurring downstream of IGF-1 are very similar to the insulin signal; *i.e.*, PI3K or AKT signaling. Phosphorylation of BMAL1 by insulin-AKT activation ([@bb0045]) may also be involved in IGF-1-induced entrainment. Interestingly, insulin-like peptides bind to the insulin/IGF-1 receptor in *C. elegans* and *Drosophila* ([@bb0010]), suggesting that both types of signaling equally affect SF-induced entrainment.

The mechanism of food entrainment in STZ-treated mice remains unclear. In this study, we showed that the liver circadian rhythm in STZ-treated mice was altered in response to the intake of a protein-only diet ([Fig. 3](#f0015){ref-type="fig"}a). Our results showed that compared with that in Intact mice, *Rev-Erbα* expression is decreased and serum glucagon levels were not altered by a protein-only diet intake in STZ-treated mice ([Fig. 3](#f0015){ref-type="fig"}c, d). A previous study has indicated that *Rev-Erbα* expression controls glucagon secretion ([@bb0280]); accordingly, we speculated that glucagon secretion is impaired in STZ-treated mice. On the other hand, hepatic IGF-1 levels increased through intake of a protein-only diet in STZ-treated mice ([Fig. 3](#f0015){ref-type="fig"}f). Furthermore, glucagon receptor antagonist and IGF-1R blocker experiments showed that IGF-1 plays a more important role than glucagon in protein-only diet-induced entrainment ([Fig. 4](#f0020){ref-type="fig"}). Thus, we suggested that hepatic IGF-1 production is associated with entrainment of the liver circadian clock in STZ-treated mice.

Recently, it was also reported that l-ornithine administration caused a phase advance of peripheral clocks *via* an increase in insulin secretion ([@bb0055]); however the actual amino acid responsible for the strong entrainment of peripheral circadian rhythm remained unclear. Accordingly, we analyzed whether the administration of single amino acids affects the liver circadian rhythm through *in vivo* monitoring. These results showed that cysteine elicits the strongest entrainment of liver circadian rhythm through IGF-1 production in the liver ([Figs. 5](#f0025){ref-type="fig"}c, [Fig. 6](#f0030){ref-type="fig"}, [Fig. 7](#f0035){ref-type="fig"}). Furthermore, we showed that although entrainment by cysteine treatment did not occur in MEF cells, this phenomenon is observed in *in vivo* conditions (Supplementary Fig. 10b). Therefore, cysteine itself does not alter circadian rhythms, but the alteration is achieved *via* the generation of IGF-1. Supplementation with the branched-chain amino acids isoleucine and leucine decreased serum IGF-1 levels, whereas supplementation with the aromatic amino acids phenylalanine and histidine increased serum IGF-1 levels ([@bb0050]). Moreover, a cysteine-supplemented diet increased hepatic IGF-1 mRNA expression and serum IGF-1 levels ([@bb0175]). The present findings were consistent with these previously reported results.

It has been reported that a breakfast high in protein reduces the subsequent consumption of high-fat food by decreasing ghrelin levels and increasing peptide YY levels ([@bb0150]). Furthermore, we reported that food intake after a starvation period, such as at breakfast, results in large phase shifts of the liver ([@bb0085]). The results of these previous studies and our present study suggest that the consumption of a high-protein breakfast entrains peripheral circadian rhythm and prevents obesity, thus resulting in beneficial effects on health. Moreover, our identification of insulin-independent mechanisms may be particularly appropriate for patients with T2DM.

It is known that circulating IGF-1 levels decrease with age, leading to the induction of osteoporosis and sarcopenia ([@bb0065]). However, circulating IGF-1 levels have been shown to increase by the intake of high-protein meals in adults aged 50--65 years ([@bb0155]). Moreover, we recently reported that food-induced entrainment is not desynchronized in aged mice compared with young mice ([@bb0260]). These previous studies and our present study show that the intake of high-protein meals increases circulating IGF-1 levels and regulates the resetting of peripheral circadian clocks in older individuals; thus, the consumption of high-protein meals for breakfast might be beneficial for health. An increase in circulating IGF-1 levels is beneficial for older people; however, an excessive increase in circulating IGF-1 levels is detrimental to young people, leading to cancer cell proliferation ([@bb0155]). In addition, the entrainment pathway of IGF-1 production might be beneficial for T2DM patients with disrupted insulin signaling. In the current study, we analyzed whether SF of a 20% casein diet (AIN-93G diet) can increase glucagon and IGF-1 levels. Our results demonstrated an increase in insulin and glucagon levels but not IGF-1 levels, suggesting a more crucial role of insulin/glucagon than IGF-1 in young WT mice. Thus, the increase in IGF-1 but not insulin increase by a protein-rich diet may be beneficial for entrainment in some situations but not all cases. As summarized in Supplementary Fig. 11, food-induced entrainment occurs *via* different signaling pathways depending on the specific components of the diet consumed.

In summary, we demonstrated that both a protein-only diet and cysteine administration elicits entrainment of hepatic circadian rhythms in mice. Furthermore, we suggested that this occurs *via* glucagon secretion and IGF-1 production. Our findings broaden the potential application of chronotherapeutic agents for patients with circadian rhythm disorders, shift work, and those suffering from jet lag.
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[^1]: Rhythmicity \* *P* \< 0.05, \*\* *P* \< 0.01, \*\*\* *P* \< 0.001.
